These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 12771991)
1. NESP55, a novel chromogranin-like peptide, is expressed in endocrine tumours of the pancreas and adrenal medulla but not in ileal carcinoids. Jakobsen AM; Ahlman H; Kölby L; Abrahamsson J; Fischer-Colbrie R; Nilsson O Br J Cancer; 2003 Jun; 88(11):1746-54. PubMed ID: 12771991 [TBL] [Abstract][Full Text] [Related]
2. Neuroendocrine secretory protein-55 (NESP-55) expression discriminates pancreatic endocrine tumors and pheochromocytomas from gastrointestinal and pulmonary carcinoids. Srivastava A; Padilla O; Fischer-Colbrie R; Tischler AS; Dayal Y Am J Surg Pathol; 2004 Oct; 28(10):1371-8. PubMed ID: 15371954 [TBL] [Abstract][Full Text] [Related]
3. Importance of vesicle proteins in the diagnosis and treatment of neuroendocrine tumors. Nilsson O; Jakobsen AM; Kölby L; Bernhardt P; Forssell-Aronsson E; Ahlman H Ann N Y Acad Sci; 2004 Apr; 1014():280-3. PubMed ID: 15153446 [TBL] [Abstract][Full Text] [Related]
4. IMP3, NESP55, TTF-1 and CDX2 serve as an immunohistochemical panel in the distinction among small-cell carcinoma, gastrointestinal carcinoid, and pancreatic endocrine tumor metastasized to the liver. Denby KS; Briones AJ; Bourne PA; Spaulding BO; Lu D; Fischer-Colbrie R; Qu Z; Wang HL; Xu H Appl Immunohistochem Mol Morphol; 2012 Dec; 20(6):573-9. PubMed ID: 22495359 [TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical distribution of chromogranins A and B and secretogranin II in neuroendocrine tumours of the gastrointestinal tract. Fahrenkamp AG; Wibbeke C; Winde G; Ofner D; Böcker W; Fischer-Colbrie R; Schmid KW Virchows Arch; 1995; 426(4):361-7. PubMed ID: 7599788 [TBL] [Abstract][Full Text] [Related]
7. Expression of synaptic vesicle protein 2 (SV2) in neuroendocrine tumours of the gastrointestinal tract and pancreas. Jakobsen AM; Ahlman H; Wängberg B; Kölby L; Bengtsson M; Nilsson O J Pathol; 2002 Jan; 196(1):44-50. PubMed ID: 11748641 [TBL] [Abstract][Full Text] [Related]
8. Neuroendocrine secretory protein 55: a novel marker for the constitutive secretory pathway. Fischer-Colbrie R; Eder S; Lovisetti-Scamihorn P; Becker A; Laslop A Ann N Y Acad Sci; 2002 Oct; 971():317-22. PubMed ID: 12438142 [TBL] [Abstract][Full Text] [Related]
9. Molecular cloning and characterization of NESP55, a novel chromogranin-like precursor of a peptide with 5-HT1B receptor antagonist activity. Ischia R; Lovisetti-Scamihorn P; Hogue-Angeletti R; Wolkersdorfer M; Winkler H; Fischer-Colbrie R J Biol Chem; 1997 Apr; 272(17):11657-62. PubMed ID: 9111083 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical staining for CDX-2, PDX-1, NESP-55, and TTF-1 can help distinguish gastrointestinal carcinoid tumors from pancreatic endocrine and pulmonary carcinoid tumors. Srivastava A; Hornick JL Am J Surg Pathol; 2009 Apr; 33(4):626-32. PubMed ID: 19065104 [TBL] [Abstract][Full Text] [Related]
11. Chromogranin A: its clinical value as marker of neuroendocrine tumours. Nobels FR; Kwekkeboom DJ; Bouillon R; Lamberts SW Eur J Clin Invest; 1998 Jun; 28(6):431-40. PubMed ID: 9693933 [TBL] [Abstract][Full Text] [Related]
12. Highlights of the biology of endocrine tumours of the gut and pancreas. Rindi G; Bordi C Endocr Relat Cancer; 2003 Dec; 10(4):427-36. PubMed ID: 14713255 [TBL] [Abstract][Full Text] [Related]
13. PAX8 Expression in well-differentiated pancreatic endocrine tumors: correlation with clinicopathologic features and comparison with gastrointestinal and pulmonary carcinoid tumors. Long KB; Srivastava A; Hirsch MS; Hornick JL Am J Surg Pathol; 2010 May; 34(5):723-9. PubMed ID: 20414099 [TBL] [Abstract][Full Text] [Related]
14. Defining molecular classifications and targets in gastroenteropancreatic neuroendocrine tumors through DNA microarray analysis. Duerr EM; Mizukami Y; Ng A; Xavier RJ; Kikuchi H; Deshpande V; Warshaw AL; Glickman J; Kulke MH; Chung DC Endocr Relat Cancer; 2008 Mar; 15(1):243-56. PubMed ID: 18310291 [TBL] [Abstract][Full Text] [Related]
15. [Pheochromocytoma--pathohistologic and immunohistochemical aspects]. Tatić S; Havelka M; Paunović I; Bozić V; Diklic A; Brasanac D; Janković R; Jancić-Zguricas M Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():7-13. PubMed ID: 12584991 [TBL] [Abstract][Full Text] [Related]
16. Measurements of chromogranin A, chromogranin B (secretogranin I), chromogranin C (secretogranin II) and pancreastatin in plasma and urine from patients with carcinoid tumours and endocrine pancreatic tumours. Stridsberg M; Oberg K; Li Q; Engström U; Lundqvist G J Endocrinol; 1995 Jan; 144(1):49-59. PubMed ID: 7891024 [TBL] [Abstract][Full Text] [Related]
17. Distribution and intraneuronal trafficking of a novel member of the chromogranin family, NESP55, in the rat peripheral nervous system. Li JY; Lovisetti-Scamihorn P; Fischer-Colbrie R; Winkler H; Dahlström A; Neuroscience; 2002; 110(4):731-45. PubMed ID: 11934480 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of membrane proteins in primary and metastatic gastrointestinal neuroendocrine tumors. Carr JC; Sherman SK; Wang D; Dahdaleh FS; Bellizzi AM; O'Dorisio MS; O'Dorisio TM; Howe JR Ann Surg Oncol; 2013 Dec; 20 Suppl 3(0 3):S739-S746. PubMed ID: 24114056 [TBL] [Abstract][Full Text] [Related]
19. Uptake of meta-iodobenzylguanidine in neuroendocrine tumours is mediated by vesicular monoamine transporters. Kölby L; Bernhardt P; Levin-Jakobsen AM; Johanson V; Wängberg B; Ahlman H; Forssell-Aronsson E; Nilsson O Br J Cancer; 2003 Oct; 89(7):1383-8. PubMed ID: 14520475 [TBL] [Abstract][Full Text] [Related]
20. The new chromogranin-like protein NESP55 is preferentially localized in adrenaline-synthesizing cells of the bovine and rat adrenal medulla. Bauer R; Weiss C; Marksteiner J; Doblinger A; Fischer-Colbrie R; Laslop A Neurosci Lett; 1999 Mar; 263(1):13-6. PubMed ID: 10218899 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]